Determinants for inadequate glycaemic control in Chinese patients with mild-to-moderate type 2 diabetes on oral antidiabetic drugs alone

Chinese Medical Journal

Volumn 124, Issue 16, 2011, Pages 2461-2468

  Zhang, Shao Ling ^a   Chen, Zong Cun ^a   Yan, Li ^a   Chen, Li Hong ^a   Cheng, Hua ^a   Ji, Li Nong ^b  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Glycaemic control; Haemoglobin a1c; Obsevational study; Oral antidiabetic drug; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHINESE; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; HEALTH STATUS; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; SELF REPORT;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 80051996162     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.16.012     Document Type: Article

References (36)

1. Yang WY. Achieve great success, and blaze a trail: review of clinical and basic research progress of Chinese diabetes in the 21st century. Chin Med J 2009; 122: 2525-2529.
2. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405.
3. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101.
4. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997; 20: 1664-1669.
5. Dong Y, Gao W, Nan H, Yu H, Li F, Duan W, et al. Prevalence of Type 2 diabetes in urban and rural Chinese populations in Qingdao, China. Diabet Med 2005; 22: 1427-1433.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
7. Ray KK, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765-1772.
8. Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia 2002; 45: S23-S28.
9. Alvarez Guisasola F, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study. Diabetes Obes Metab 2008; 10 (Suppl 1): 8-15.
10. Tokuyama Y, Ishizuka T, Matsui K, Egashira T, Kanatsuka A. Predictors of glycemic control in Japanese subjects with type 2 diabetes mellitus. Metabolism 2008; 57: 453-457.
11. Chan JC, Baik SH, Chantelot JM, Ferreira SR, Hancu N, Ilkova H, et al. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care JT - Diabetes care 2009; 32: 227-233.
12. Benoit SR, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study. BMC Public Health JT - BMC public health 2005; 5: 36.
13. Mendes AB, Fittipaldi JA, Neves RC, Chacra AR, Moreira ED Jr. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil. Acta Diabetol 2010; 47: 137-145.
14. Esposito K, Maiorino MI, Di Palo C, Giugliano D. Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitus. Diabet Med 2009; 26: 900-907.
15. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987; 10: 617-621.
16. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, compre-hensive, and minimal care. Diabet Med 2006; 23: 579-593.
17. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
18. Chinese Medical Association Subsection of Cardiovascular Disease, Chinese Journal of Cardiology Editorial Board. Highlights of the Second National Conference on Dyslipidemia. Chin J Cardiol (Chin) 2002; 30: 643-646.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Cureton EE, D'Agostino RB. Factor analyses: an applied approach. Lawrence Eribaum Associates Hillsdale NJ; 1983.
21. Pan C, Yang W, Jia W, Weng J, Tian H. Management of Chinese patients with type 2 diabetes, 1998-2006: the Diabcare-China surveys. Curr Med Res Opin 2009; 25: 39-45.
22. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 1998; 15: 297-303.
23. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004; 27: 1535-1540.
24. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006; 368: 1696-1705.
25. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003; 26: 881-885.
26. Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res Clin Pract 2007; 77: 280-285.
27. Kavouras SA, Panagiotakos DB, Pitsavos C, Chrysohoou C, Anastasiou CA. Physical activity, obesity status, and glycemic control: The ATTICA study. Med Sci Sports Exerc 2007; 39: 606-611
28. Yaney GC, Corkey BE. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia 2003; 46: 1297-1312.
29. Johnson JH, Ogawa A, Chen L, Orci L, Newgard CB, Alam T, et al. Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes. Science 1990; 250: 546-549.
30. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, et al. Triglycerides and the risk of coronary heart disease: 10 158 incident cases among 262 525 partici-pants in 29 Western prospective studies. Circulation 2007; 115: 450-458.
31. Tonkin AM, Chen L. Effects of combination lipid therapy in the management of patients with Type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Circulation 2010; 122: 850-852.
32. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjust-ment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-1972.
33. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 30(Suppl 1): S11-S61.
34. Davidson MB, Hu T, Sain G, Hoar B, Stevenson C, Hoogwerf BJ. The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study. Diabetes Obes Metab 2009; 11: 118-122.
35. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
36. Gordon T. Hazards in the use of the logistic function with special reference to data from prospective cardiovascular studies. J Chron Dis 1974; 27: 97-102.